Chargement en cours...
CD22ΔE12 as a molecular target for RNAi therapy
B-precursor acute lymphoblastic leukemia (BPL) is the most common form of cancer in children and adolescents. Our recent studies have demonstrated that CD22ΔE12 is a characteristic genetic defect of therapy-refractory clones in pediatric BPL and implicated the CD22ΔE12 genetic defect in the aggressi...
Enregistré dans:
| Publié dans: | Br J Haematol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4486322/ https://ncbi.nlm.nih.gov/pubmed/25659406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13306 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|